New in the 2017 edition of AMR Control


In this edition we have five key sections: Governance, One Health, Healthcare, Economics and R&D which reflect the broad approach required to cover all the issues involved in AMR. Highlights include:


  • “Best of” in national plans and Governance with the example of Germany and Senegal, notably and of large countries facing huge challenges: China and small countries like Lebanon.
  • Germany leads the G20 in putting AMR on the agenda and has an exemplary national programme.
  • Senegal is a leader on the African continent, has moved way ahead in AMR control, notably with a focus on infection prevention and surveillance, while engaging other African State representatives with training seminars.
  • The critical issues of AMR in health services: Intensive care units and surgery
  • A special section on the One Health approach (WHO, FAO, OIE) explained by its leaders and the interconnectedness of animal and human health. This was one of the key components of the UN High-Level Declaration on AMR.
  • The Economics of AMR: the latest from the World Bank, the efforts to quantify AB from an economic strandpoint (with ASSIST URC), and the poverty-AMR links with CDDEP.
  • R&D with the report from the BARDA (Biomedical Advanced R&D Authority) in the United States and important alternative insights on treating AMR from  plant research.
  • AMR as a Global Health Security Threat with an Australian team.

In this edition you will find many prominent writers addressing a wide range of issue. These include:

  • The World Bank Group on AMR, with Dr Enis Baris and Dr Timothy Evans, Senior Directorof the  Health, Population and Nutrition Global Practice.
  • Senegal’s Minister of Health, H.E. Professor Awa Coll Seck with Dr Pape Amadou Diack, DG Health, and team looking at the Senegalese AMR plan.
  • The Federal Republic of Germany Ministry of Health with Dr K Knufmann-Happe, DG for Health Protection, Disease Control and Biomedicine outlines the German national plan.
  • The US Biomedical Advanced Research and Development Authority (BARDA) initiative with its Director Christopher Houchens, Ph.D. and Joe Larsen PhD explains about their work.
  • The USAID-URC Assist project team with Dr Rashad Massoud on IPC, Dr Tamar Chitashvili (first study on AB prescribing in Uganda), Edward Broughton (on economics of AB prescribing) and the new group investigating HAI in Palestine.
  • The China AMR plans are detailed by Profssor Xiao from the National State Laboratory.
  • The WHO Tuberculosis leadership and MDR-TB with Dr Mario Raviglione, Karin Weyer, and team.
  • The OIE’s involvement in AMR with Dr Elisabeth Erlacher-Vindel, head, Scientific and Technical Department
  • Updates from WHO-AGISAR with Chair Dr Awa Aidara Kane and John Hopkins University’s. Professor Ellen Silbergeld.
  • The Lebanese AMR plan with WHO STAG Member Professor Salame,
  • The importance of looking at AMR in the Intensive Care Unit with Jean Carlet and Jan de Waele, Belgium
  • A new coalition to combat AMR in Surgery with Massimo Sartelli.
  • The Algerian Ministry of Health with the AFRO group at WHO linking up AMR and drug access.
  • A glimpse of alternatives to antibiotics discoveries on the horizon with Professor Cassandra L Quave who made headlines in the United States with the anti-MRSA properties of the Brazilian Peppertree and researcher Nora Mahfouf, on the antimicrobial properties of Oregano essential oil.